- Home
- Publications
- Publication Search
- Publication Details
Title
Tracking the COVID-19 vaccines: The global landscape
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 19, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-03-31
DOI
10.1080/21645515.2023.2191577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
- (2023) Hung Fu Tseng et al. Nature Communications
- Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages
- (2023) Jinal N. Bhiman et al. Scientific Reports
- Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
- (2023) Lorenzo Azzi et al. EBioMedicine
- SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
- (2022) Kimberly A Kraynyak et al. JOURNAL OF INFECTIOUS DISEASES
- Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern
- (2022) Shailendra K. Saxena et al. JOURNAL OF MEDICAL VIROLOGY
- Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
- (2022) Alexander Muik et al. SCIENCE
- SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
- (2022) Tara M. Narowski et al. Cell Reports
- SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses
- (2022) Debashree Chatterjee et al. Cell Reports
- Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19
- (2022) Swatantra Kumar et al. Frontiers in Immunology
- Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
- (2022) Akash Khobragade et al. LANCET
- DNA vaccines join the fight against COVID-19
- (2022) Anna K Blakney et al. LANCET
- Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
- (2022) Dean Follmann et al. ANNALS OF INTERNAL MEDICINE
- Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
- (2022) Jinyi Tang et al. Science Immunology
- Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b–2a trial
- (2022) Shabir A Madhi et al. LANCET INFECTIOUS DISEASES
- BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
- (2022) Sara Y Tartof et al. LANCET INFECTIOUS DISEASES
- AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
- (2022) Anastasia A. Aksyuk et al. Cell Reports Medicine
- Looking beyond COVID-19 vaccine phase 3 trials
- (2021) Jerome H. Kim et al. NATURE MEDICINE
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
- (2021) Leonidas Stamatatos et al. SCIENCE
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- A global database of COVID-19 vaccinations
- (2021) Edouard Mathieu et al. Nature Human Behaviour
- Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
- (2021) Kashif Ali et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early approval of COVID-19 vaccines: Pros and cons
- (2021) Md Arifur Rahman et al. Human Vaccines & Immunotherapeutics
- Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
- (2021) Alexandra Tauzin et al. Cell Host & Microbe
- A brief review on DNA vaccines in the era of COVID-19
- (2021) Maryam Shafaati et al. Future Virology
- India’s New COVID-19 DNA Vaccine for Adolescents and Adults Is a First
- (2021) Jennifer Abbasi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- First COVID-19 DNA vaccine approved, others in hot pursuit
- (2021) Cormac Sheridan NATURE BIOTECHNOLOGY
- Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
- (2021) Ann R. Falsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- (2021) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 Vaccine Effectiveness in New York State
- (2021) Eli S. Rosenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
- (2021) Lorenzo Azzi et al. EBioMedicine
- INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
- (2021) Viviane M. Andrade et al. npj Vaccines
- Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins
- (2020) Suhas Srinivasan et al. Viruses-Basel
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant vaccines for COVID-19
- (2020) Tushar Yadav et al. Human Vaccines & Immunotherapeutics
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started